---
title: Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated
  Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma
date: '2023-07-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37485886/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230724180956&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Patients with pancreatic ductal adenocarcinoma (PDAC) have a dismal 5
  year survival of 9%. One important limiting factor for treatment efficacy is the
  dense tumor-supporting stroma. The cancer-associated fibroblasts in this stroma
  deposit excessive amounts of extracellular matrix components and anti-inflammatory
  mediators, which hampers the efficacy of chemo- and immunotherapies. Systemic depletion
  of all activated fibroblasts is, however, not feasible nor desirable and therefore
  a ...
disable_comments: true
---
Patients with pancreatic ductal adenocarcinoma (PDAC) have a dismal 5 year survival of 9%. One important limiting factor for treatment efficacy is the dense tumor-supporting stroma. The cancer-associated fibroblasts in this stroma deposit excessive amounts of extracellular matrix components and anti-inflammatory mediators, which hampers the efficacy of chemo- and immunotherapies. Systemic depletion of all activated fibroblasts is, however, not feasible nor desirable and therefore a ...